Abstract
Stratum corneum (SC), the outermost layer of the skin, constitutes an excellent protective physiological barrier, and is the main challenge in transdermal drug delivery. Many approaches have been used to enhance the penetration of drugs through this layer, covering passive and active methods or the combination of both. This opens the opportunity to broaden the spectrum of drugs that can be administered through the skin, providing alternatives to existing products, and filling gaps that conventional routes failed to occupy. In this review, an overview of the different permeation enhancing methodologies is carried out, focusing on the combination of lipid nanoparticles with conventional chemical enhancers, as a proof-of-concept of a successful development strategy.
Keywords: Active methods, chemical penetration enhancers, lipid nanoparticles, microneedles, passive methods, permeation enhancement, transdermal delivery.
Current Pharmaceutical Design
Title:Overcoming the Skin Permeation Barrier: Challenges and Opportunities
Volume: 21 Issue: 20
Author(s): Carla Vitorino, Joao Sousa and Alberto Pais
Affiliation:
Keywords: Active methods, chemical penetration enhancers, lipid nanoparticles, microneedles, passive methods, permeation enhancement, transdermal delivery.
Abstract: Stratum corneum (SC), the outermost layer of the skin, constitutes an excellent protective physiological barrier, and is the main challenge in transdermal drug delivery. Many approaches have been used to enhance the penetration of drugs through this layer, covering passive and active methods or the combination of both. This opens the opportunity to broaden the spectrum of drugs that can be administered through the skin, providing alternatives to existing products, and filling gaps that conventional routes failed to occupy. In this review, an overview of the different permeation enhancing methodologies is carried out, focusing on the combination of lipid nanoparticles with conventional chemical enhancers, as a proof-of-concept of a successful development strategy.
Export Options
About this article
Cite this article as:
Vitorino Carla, Sousa Joao and Pais Alberto, Overcoming the Skin Permeation Barrier: Challenges and Opportunities, Current Pharmaceutical Design 2015; 21 (20) . https://dx.doi.org/10.2174/1381612821666150428124053
DOI https://dx.doi.org/10.2174/1381612821666150428124053 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanotechnology in Therapeutics – Current Technologies and Applications
Current Nanoscience Therapy Based on the Regulation of Thiol-dependent Redox Systems
Current Medicinal Chemistry Clopidogrel High On-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy. A Pilot Study
Current Vascular Pharmacology Telomere End Protection in Stem Cells and Cancer Cells
Current Cancer Therapy Reviews Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases
CNS & Neurological Disorders - Drug Targets Lactobacillus Rhamnosus Cell Lysate in the Management of Resistant Childhood Atopic Eczema
Inflammation & Allergy - Drug Targets (Discontinued) Postnatal Growth Restriction in Preterm Infants: A Major Impact of Nutritional Practices and Methods of Assessment
New Emirates Medical Journal Progress in the Research on Naturally Occurring Flavones and Flavonols: An Overview
Current Organic Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Pioglitazone and Cancer: Angel or Demon?
Current Pharmaceutical Design Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
Current Drug Targets - Cardiovascular & Hematological Disorders Association between Apo B Levels in Mothers and in their Pre-school Age Offspring
Cardiovascular & Hematological Agents in Medicinal Chemistry Mathematical Modeling of the Cancer Cell ’ s Control Circuitry: Paving the Way to Individualized Therapeutic Strategies
Current Signal Transduction Therapy HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities
Current HIV Research A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
Current Medicinal Chemistry Characterization and Antioxidant Activity of Quercetin/Methyl-β-Cyclodextrin Complexes
Current Drug Delivery Structure Guided Molecular Docking Assisted Alignment Dependent 3DQSAR Study on Steroidal Aromatase Inhibitors (SAIs) as Anti-breast Cancer Agents
Letters in Drug Design & Discovery Excess Cardiovascular Risk in Inflammatory Rheumatic Diseases: Pathophysiology and Targeted Therapy
Current Pharmaceutical Design Subject Index to Volume 10
Current Medicinal Chemistry The Hypothalamus and Obesity
Recent Patents on CNS Drug Discovery (Discontinued)